What they actually do
Combines patient recruitment with site identification and community outreach, with a stated emphasis on enrolling underrepresented populations — increasingly a regulatory expectation rather than a nice-to-have.
How they price
Scoped services, often blended site-identification plus recruitment programs.
Whatever the structure, convert it to cost per randomized patient before you compare proposals. Cost per referral is the number vendors prefer to quote and the number that tells you least.
Where they are strong
- Community-level outreach capability
- Helps address diversity action plan commitments
- Site identification as well as patient supply
What to watch for
- Community outreach takes time to build; plan it before first patient in, not after
Is CSSi worth it?
Worth it when: Programs with explicit diversity enrollment commitments.
Not worth it when: Studies where the diversity plan is already handled by another partner.
CSSi alternatives
Before you sign anything
Ask for the referral-to-randomization ratio on three studies resembling yours, in the same indication and the same countries. If a vendor will not give it, that is the answer. If your enrollment forecast itself is the shaky part, our sister publication Rock Enroll covers forecasting and rescue in depth.
This profile is compiled from public sources: the company's own website and case studies, trial registries, and trade press. Statements about performance are framed as questions to put to the vendor rather than claims about it. CSSi did not review or approve this page. Corrections are welcome and get made.